Blood Tumor Mutational Burden as a Predictive Biomarker in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

This study was designed to investigate the impact of blood tumor mutational burden (bTMB) on advanced NSCLC in Southwest China. The relationship between the tTMB estimated by next-generation sequencing (NGS) and clinical outcome was retrospectively analyzed in tissue specimens from 21 patients with...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Oncol
Autori principali: Ma, Yuhui, Li, Quan, Du, Yaxi, Cai, Jingjing, Chen, Wanlin, Zhao, Guangqiang, Liu, Xing, Li, Hongsheng, Ma, Luyao, Huang, Yunchao, Zhou, Yongchun
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2021
Soggetti:
Oncology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8160368/
https://ncbi.nlm.nih.gov/pubmed/34055609
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.640761
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi